Cipla’s US unit recalls over 400 cartons of anti-cancer drug Nilotinib
New Delhi, March 8 (IANS) A US-based subsidiary of Cipla has recalled more than 400 cartons of a generic anti-cancer medicine due to a manufacturing issue, according to the US Food and Drug Administration (USFDA).